z-logo
open-access-imgOpen Access
Long-term outcome of Gamma Knife radiosurgery in patients with tiny intracanalicular vestibular schwannomas detected by three-dimensional fast imaging employing steady-state acquisition magnetic resonance
Author(s) -
Chain-Fa Su,
Chou-Chin Lee,
Jenn Ming Yang,
Tzu-Wen Loh,
Jia-Huey Tzou,
Dai-Wei Liu
Publication year - 2014
Publication title -
tzu-chi medical journal/cí-jì yīxué
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.343
H-Index - 15
eISSN - 2223-8956
pISSN - 1016-3190
DOI - 10.1016/j.tcmj.2014.07.003
Subject(s) - medicine , radiosurgery , vestibular schwannomas , magnetic resonance imaging , nuclear medicine , vertigo , vestibular system , acoustic neuroma , vestibular nerve , surgery , radiology , radiation therapy
ObjectiveTo evaluate the effectiveness and long-term outcome of Gamma Knife radiosurgery (GKRS) for tiny vestibular schwannomas (VSs) detected by three-dimensional fast imaging employing steady-state acquisition magnetic resonance (3D-FIESTA MR).Materials and methodsBetween January and December 2004, 3D-FIESTA MR of the brain was performed in patients who had physical health examinations at the Buddhist Tzu Chi General Hospital (Hualien, Taiwan). Tiny intracanalicular VSs (defined as a tumor volume < 0.5 cm2) was detected in 13 patients (8 women and 5 men). The mean age of the patients was 60 years (range, 45–84 years). Hearing function was graded using the Gardner–Robertson (GR) classification. Dose planning was performed on intraoperative stereotactic contrast-enhanced images using multiple 4-mm isocenters. The mean tumor volume was 0.098 cm2 (range, 0.013–0.4 cm2). The mean margin dose was 12.4 Gy (range, 11–14 Gy), and the isodose line was set at a mean of 53.8% (range, 50–70%).ResultsTwelve patients had GR Grade I or II hearing before GKRS, and GR I or II hearing was maintained in 11 patients. Facial and trigeminal nerve functions were preserved in all patients. The tumor control rate was 100% at a mean follow-up period of 9.8 ± 1.1 years (range, 76–126 months). One patient developed acute vertigo 1 day after GKRS, which subsided after short-term use of steroids and did not recur.ConclusionWith the application of 3D-FIESTA, tiny VSs can be detected early. Because low-dose (12–14 Gy) GKRS is safe and effective for long-term control of the growth of tumors with acceptable preservation rate of hearing function, it may be worthwhile to use 3D-FIESTA to detect tiny VSs and treat the patients using GKRS

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here